The business strategies of companies involved in chiral drug development were cast into doubt in October after Eli Lilly (Indianapolis, IL) decided not to pursue the development of R-fluoxetine ...

Since biomolecules such as amino acids, sugars and proteins in our body all have the same handedness, active pharmaceutical ingredients must also be chiral. A drug with the wrong handedness is ...

Developing racemic (mixed-enantiomer) drugs is on the way out, industry analysts say, because pharmaceutical companies must evaluate the individual enantiomers and the combination. "Nearly every ...

"This approach offers unprecedented and relatively easy access to a broad set of chiral carbocycles that are privileged structures for pharma industry drug discovery programs," says study senior ...

Understanding and controlling chirality at the nanoscale is crucial for various applications, including drug development, catalysis, and materials science. Chiral Au nanorod and its helicity map that ...